Corticosteroids + Ustekinumab Srlf Interaction
Moderateinteraction on record
Description
Used concomitantly in approximately 40-50% of Crohn's disease and ulcerative colitis subjects; did not appear to influence overall safety or efficacy of ustekinumab.
Source: NLP:ustekinumab-srlf